Can hedge funds and institutional investors buy/trade penny

New Post Public Reply Private Reply Replies (0) Message Board
riskreward007 LVgliders #37709
523
Can hedge funds and institutional investors buy/trade penny stocks under $5?

It looks like most HEDGE FUNDS AND INSTITUTIONS CAN BUY PENNY STOCKS BUT CHOOSE NOT TO DO SO for various reasons (see the two articles below).

https://pubcoceo.com/2019/01/28/can-instituti...ny-stocks/

https://www.fool.com/investing/2017/11/06/can...der-5.aspx

Note: I was recently looking into Fisher Investments a a global money management firm headquartered in Camas, Washington that has $120 billion in assets under management, and I noticed that they do have penny stocks in their portfolio. However, their investments in penny stocks are very small relative to the other equities in their portfolio (usually around $2k or less, and purely speculative).

Any OTC/penny stock that reaches the NASDAQ is no longer considered a penny stock.

Re: Penny stock myths:

One myth is that “Institutions cannot trade penny stocks.”
Israel writes; “Many people assume that the penny stock market is made up entirely of retail traders and that institutions are prohibited from participating in the market, but this is actually not the case. This myth may have gained credence based on historical restrictions or prohibitions on OTC stocks, but these are no longer true. Institutions follow opportunity—be that in penny stocks or larger, more liquid securities.”

While many small/micro-cap professionals may have heard that institutions can’t trade their stocks. Often, institutions can trade these stocks but they avoid them.

Institutional Investors don’t trade most penny stocks for 4 reasons:


Minimum Market Cap . “Many funds will have a minimum market cap requirement, and even where this is not an official policy, we often find that fund managers draw their own line in the sand.”

Liquidity Concerns.  Many fund fear getting stuck in an illiquid holding.

Corporate Governance.  Institutional funds are concerned with poor levels of corporate governance and disclosure among microcaps, “a perception reinforced by high profile corporate scandals.”

Materiality.  No matter the size of investment, fund managers must perform a similar level of due diligence for each investment. The size of microcaps compared to the size of most institutions means a meaningful investment cannot be made.

Can Mutual Funds Own Stocks Under $5?

An institutional bias against penny stocks isn't as real as commonly believed.

Jordan Wathen
fool.com
Nov 6, 2017

It's often said that mutual funds and other institutional investors can't own stocks that trade for less than $5, condemning low-priced stocks to retail ownership only. But the truth is actually the opposite -- there are some roadblocks for investing in penny stocks, but they are most applicable to average Joes, not professional investors who run institutional sums.

Why share prices matter (and why they don't):

Mathematically, a company worth $10 billion is still worth $10 billion, whether it is sliced into $1 shares or $1,000 shares. However, the government takes a different view due to laws passed to thwart bad brokerage practices.

Congress put share prices in the spotlight when it made it more difficult for brokers to process client transactions in stocks priced lower than $5 each, the cutoff point below which a stock earns the "penny stock" label.

These regulations were put into place following a broad crackdown on sketchy stock brokers in the early 1990s. Back then, brokerages sold penny stocks of questionable quality to investors all around the country by phone, charging huge commissions on each trade.

These folks weren't bad at picking good stocks, but rather good at selling bad stocks. One of the largest busted brokerages was J.T. Moran, which was the basis for the story in the movie Boiler Room. Stratton Oakmont, featured in Wolf of Wall Street, fits the description, too. You get the idea here.

How Congress dealt with penny stock salesmen
Congress decided that it needed to make it harder for individual investors to buy bad stocks, deciding to make $5 the dividing line between "good" and "bad" stocks. And with new rules in place, it immediately became all that much harder for brokers to pitch stocks that trade for less than $5 per share.

According to the Securities and Exchange Commission, brokers can't process trades in stocks worth less than $5 without following a laundry list of rules and processes. Before transacting in penny stocks, brokers must first:

1. Approve the customer for the transaction
2. Receive a written agreement for the transaction
3. Provide the customer a disclosure statement that describes the risk of investing in penny stocks
4. Disclose the current market price for the stock
5. Disclose how much the firm and broker will receive for processing the trade

The rules are reflective of the times in which they were adopted. In the 1980s and 1990s, commissions were generally assessed on a per-share basis, rather than on a flat fee basis that is the standard today. Thus, brokers made more by selling 2,000 shares of a $1 stock than 10 shares of a $200 stock, which is why penny stocks were commonly pitched by the sleaziest of stockbrokers, and why Congress targeted penny stocks with legislation.

What about institutional investors?
Mutual funds and other institutional investors may choose to avoid stocks priced at less than $5 per share, but there are no specific rules or laws prohibiting the practice. 

In fact, one of the largest actively managed stock funds on the market today is the Fidelity Low-Priced Stock Fund (NASDAQMUTFUND:FLPSX), which specifically seeks to invest in stocks priced at less than $35 per share. It launched in 1989 at the height of the public's love affair with low-priced stocks, and has crushed the market since inception. (Its focus on low-priced stocks may be more of a guide than a rule today, since its five largest investments all trade for more than $35 per share, a testament to the fact that self-imposed restrictions are rarely set in stone.)

Of course, index funds are more prominent today than in the past, and many have a mandate to own all stocks in the index they track, regardless of share prices. The S&P 500 Index, and the funds that track it, all have at least one penny stock in their portfolio, Chesapeake Energy. The Russell 2000 Index, which is generally regarded as the small cap stock index, includes 157 penny stocks, based on my analysis of the iShares Russell 2000 ETF. 

Realistically, penny stocks don't make up a large part of the market in terms of value, but they are numerous, and many are owned by funds because share prices are largely irrelevant to the decision to buy or sell. Professional investors know that a stock that trades for $4 that they believe to be worth $10 is a far better investment than a $40 stock they believe to be worth $50.

The next time someone tells you that a stock that has dropped will drop even further when institutions are forced to sell below $5, refer them to this article. Though the average Joe may face a few hurdles when buying or selling stocks under $5, there is no meaningful institutional bias against stocks that trade for less than $5 each. In fact, thanks to the rise of index funds, there are perhaps more funds that are required by their mandate to buy penny stocks than funds that purposefully exclude them.

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 30

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 22

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 30

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 22

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Quaker Chemical Experiences 52-Week Low Amid Market Challenges

Updated Category News Views 129

Quaker Chemical Faces Significant Market Challenges In a challenging market climate, Quaker Chemical Corporation (NYSE: KWR) recently saw its stock plummet to a 52-week low of $138.97. This specialty chemical company, renowned for its high-performance process fluids and coatings utilized in metalworking, has undergone considerable struggles over the past year, leading to...

Continue Reading
Aura Minerals Completes Significant Bluestone Acquisition

Updated Category News Views 124

Aura Minerals Completes Acquisition of Bluestone Resources Aura Minerals Inc. (TSX: ORA) has successfully executed its acquisition of Bluestone Resources Inc. (BBSRF) through a strategic arrangement. This transaction signals a notable expansion for Aura as it aims to enhance its precious metals portfolio. Terms of the Acquisition Under the recent agreement, shareholders...

Continue Reading
Revolutionizing Employee Benefits with Cutting-Edge Automation

Updated Category News Views 176

Employee Benefits Marketing Transformation In the landscape of employee benefits, there lies a pressing need for innovation, especially regarding effective communication and marketing engagement. Businessolver, a recognized leader in HR and benefits technology, has taken significant strides with the introduction of its Benefits Communication and Automation Engine. This...

Continue Reading
Understanding the Net Asset Value of Middlefield PCC Today

Updated Category News Views 84

Middlefield Canadian Income PCC Overview Middlefield Canadian Income PCC is a distinct investment option that focuses on providing income opportunities. Established as a protected cell company in Jersey, it adheres to well-defined regulatory standards, adding a layer of security for those who invest in it. Net Asset Value Insights In a recent evaluation, the estimated...

Continue Reading
Tarsus Pharmaceuticals Participates in Healthcare Conference

Updated Category News Views 102

Tarsus Pharmaceuticals Engages in Important Healthcare Conference Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is committed to meeting unmet medical needs through innovative scientific advancements and cutting-edge technology. The company places a strong emphasis on eye care, with the goal of transforming the treatment landscape for patients. Recently, Tarsus announced...

Continue Reading